Product Information

RANOLAZINE ER 1,000 MG TABLET is a generic product labeled by Lifestar Pharma LLC, priced at $0.2787 per EA under NDC 70756070460. Its NADAC has been published 332 times since Apr 15, 2020.

FDA first approved this application on Feb 12, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

RANOLAZINE ER 1,000 MG TABLET

Ranolazine
$0.2787per EA

Strength

1000 mg/1

NDC

70756070460

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

RANOLAZINE

Approval Type

Generic (ANDA)

FDA Application

ANDA212284

FDA Approved

2/12/2020

TE Code

AB

On Market Since

4/1/2020

Pharmacological Classes

Anti-anginal
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A Inhibitors
Organic Cation Transporter 2 Inhibitors
P-Glycoprotein Inhibitors

Price Statistics

The NADAC for RANOLAZINE ER 1,000 MG TABLET has been published 332 times since Apr 15, 2020, and over the history we have for it it has declined 69.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2787 per EA
All-time high$0.9540 (Jun 10, 2020)
All-time low$0.2725 (Apr 22, 2026)
52-week high$0.3159
52-week low$0.2725
Median price$0.3469
Average price$0.4429
Largest weekly change-21.2% (Mar 23, 2022)
Weeks tracked332
Tracking sinceApr 15, 2020

Price History

1W

-1.0%

1M

-1.0%

3M

-1.3%

6M

+1.1%

1Y

-11.8%

3Y

-14.8%

5Y

-57.4%

All

-69.8%

Generic Alternatives

The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of RANOLAZINE ER 1,000 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for RANOLAZINE ER 1,000 MG TABLET, manufactured by Lifestar Pharma LLC, is $0.2787 per EA (NDC 70756070460), effective Aug 19, 2026.

How has the price of RANOLAZINE ER 1,000 MG TABLET changed over time?

Over the history we have for it, the NADAC for RANOLAZINE ER 1,000 MG TABLET has declined 69.8%. It has been tracked across 332 weekly CMS publications since Apr 15, 2020.

What are the highest and lowest recorded NADAC prices for RANOLAZINE ER 1,000 MG TABLET?

Since Apr 15, 2020, the NADAC for RANOLAZINE ER 1,000 MG TABLET has ranged from a low of $0.2725 (Apr 22, 2026) to a high of $0.9540 (Jun 10, 2020), with a median of $0.3469 per EA.

Are there cheaper alternatives to RANOLAZINE ER 1,000 MG TABLET?

Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RANOLAZINE ER 1,000 MG TABLET, is $0.2757 per EA — about 1% below RANOLAZINE ER 1,000 MG TABLET.

Who manufactures RANOLAZINE ER 1,000 MG TABLET?

RANOLAZINE ER 1,000 MG TABLET (NDC 70756070460) is labeled by Lifestar Pharma LLC, and CMS classifies it as a generic product.